Investment analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their price target on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
View Our Latest Stock Analysis on MDRX
Veradigm Stock Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What is the Nikkei 225 index?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is Forex and How Does it Work?
- 3 Must-Own Stocks to Build Wealth This Decade
- What is a penny stock? A comprehensive guide
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
